Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 2
1968 1
1970 1
1973 1
1981 1
1985 1
1986 2
1987 2
1989 1
1990 2
1991 3
1992 3
1993 4
1994 2
1995 1
2000 1
2001 2
2003 1
2004 1
2005 1
2006 1
2007 3
2008 1
2009 6
2010 5
2011 6
2012 3
2013 5
2014 2
2015 1
2016 4
2017 5
2018 5
2019 8
2020 18
2021 19
2022 14
2023 12
2024 21
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156 results

Results by year

Filters applied: . Clear all
Page 1
Dermatologist-like explainable AI enhances trust and confidence in diagnosing melanoma.
Chanda T, Hauser K, Hobelsberger S, Bucher TC, Garcia CN, Wies C, Kittler H, Tschandl P, Navarrete-Dechent C, Podlipnik S, Chousakos E, Crnaric I, Majstorovic J, Alhajwan L, Foreman T, Peternel S, Sarap S, Özdemir İ, Barnhill RL, Llamas-Velasco M, Poch G, Korsing S, Sondermann W, Gellrich FF, Heppt MV, Erdmann M, Haferkamp S, Drexler K, Goebeler M, Schilling B, Utikal JS, Ghoreschi K, Fröhling S, Krieghoff-Henning E; Reader Study Consortium; Brinker TJ. Chanda T, et al. Among authors: drexler k. Nat Commun. 2024 Jan 15;15(1):524. doi: 10.1038/s41467-023-43095-4. Nat Commun. 2024. PMID: 38225244 Free PMC article.
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial.
Becker JC, Ugurel S, Leiter U, Meier F, Gutzmer R, Haferkamp S, Zimmer L, Livingstone E, Eigentler TK, Hauschild A, Kiecker F, Hassel JC, Mohr P, Fluck M, Thomas I, Garzarolli M, Grimmelmann I, Drexler K, Spillner AN, Eckhardt S, Schadendorf D; DeCOG. Becker JC, et al. Among authors: drexler k. Lancet. 2023 Sep 2;402(10404):798-808. doi: 10.1016/S0140-6736(23)00769-9. Epub 2023 Jul 11. Lancet. 2023. PMID: 37451295 Clinical Trial.
Machine-phase nanotechnology.
Drexler KE. Drexler KE. Sci Am. 2001 Sep;285(3):74-5. doi: 10.1038/scientificamerican0901-74. Sci Am. 2001. PMID: 11524972 No abstract available.
Faziale Lipodystrophie nach Immuntherapie mit Nivolumab.
Drexler K, Zenderowski V, Berneburg M, Haferkamp S. Drexler K, et al. J Dtsch Dermatol Ges. 2021 Oct;19(10):1513-1515. doi: 10.1111/ddg.14588_g. J Dtsch Dermatol Ges. 2021. PMID: 34661354 German. No abstract available.
nan'o.tech.nol'o.gy n.
Theis T, Parr D, Binks P, Ying J, Drexler KE, Schepers E, Mullis K, Bai C, Boland JJ, Langer R, Dobson P, Rao CN, Ferrari M. Theis T, et al. Among authors: drexler ke. Nat Nanotechnol. 2006 Oct;1(1):8-10. doi: 10.1038/nnano.2006.77. Nat Nanotechnol. 2006. PMID: 18654128 No abstract available.
Patients' and dermatologists' preferences in artificial intelligence-driven skin cancer diagnostics: A prospective multicentric survey study.
Haggenmüller S, Maron RC, Hekler A, Krieghoff-Henning E, Utikal JS, Gaiser M, Müller V, Fabian S, Meier F, Hobelsberger S, Gellrich FF, Sergon M, Hauschild A, Weichenthal M, French LE, Heinzerling L, Schlager JG, Ghoreschi K, Schlaak M, Hilke FJ, Poch G, Korsing S, Berking C, Heppt MV, Erdmann M, Haferkamp S, Drexler K, Schadendorf D, Sondermann W, Goebeler M, Schilling B, Kather JN, Fröhling S, Kaminski K, Doppler A, Bucher T, Brinker TJ; Collaborators. Haggenmüller S, et al. Among authors: drexler k. J Am Acad Dermatol. 2024 Aug;91(2):366-370. doi: 10.1016/j.jaad.2024.04.033. Epub 2024 Apr 24. J Am Acad Dermatol. 2024. PMID: 38670313 Free article. No abstract available.
Using multiple real-world dermoscopic photographs of one lesion improves melanoma classification via deep learning.
Hekler A, Maron RC, Haggenmüller S, Schmitt M, Wies C, Utikal JS, Meier F, Hobelsberger S, Gellrich FF, Sergon M, Hauschild A, French LE, Heinzerling L, Schlager JG, Ghoreschi K, Schlaak M, Hilke FJ, Poch G, Korsing S, Berking C, Heppt MV, Erdmann M, Haferkamp S, Drexler K, Schadendorf D, Sondermann W, Goebeler M, Schilling B, Kather JN, Krieghoff-Henning E, Brinker TJ. Hekler A, et al. Among authors: drexler k. J Am Acad Dermatol. 2024 May;90(5):1028-1031. doi: 10.1016/j.jaad.2023.11.065. Epub 2024 Jan 8. J Am Acad Dermatol. 2024. PMID: 38199280 Free article. No abstract available.
Federated Learning for Decentralized Artificial Intelligence in Melanoma Diagnostics.
Haggenmüller S, Schmitt M, Krieghoff-Henning E, Hekler A, Maron RC, Wies C, Utikal JS, Meier F, Hobelsberger S, Gellrich FF, Sergon M, Hauschild A, French LE, Heinzerling L, Schlager JG, Ghoreschi K, Schlaak M, Hilke FJ, Poch G, Korsing S, Berking C, Heppt MV, Erdmann M, Haferkamp S, Drexler K, Schadendorf D, Sondermann W, Goebeler M, Schilling B, Kather JN, Fröhling S, Brinker TJ. Haggenmüller S, et al. Among authors: drexler k. JAMA Dermatol. 2024 Mar 1;160(3):303-311. doi: 10.1001/jamadermatol.2023.5550. JAMA Dermatol. 2024. PMID: 38324293 Free PMC article.
156 results